← Back to guidelines
Dermatology25 papers

Drug-induced eosinophilia

Last edited: 4/15/2026

Overview

Drug-induced eosinophilia refers to an increase in peripheral blood eosinophils secondary to medication exposure, often associated with hypersensitivity reactions such as drug rash with eosinophilia and systemic symptoms (DRESS). 12

Diagnosis

  • Clinical Presentation: Fever, rash, organ involvement (renal, hepatic), peripheral eosinophilia.
  • Laboratory Tests: Complete blood count (CBC) showing eosinophilia, liver function tests, renal function tests.
  • Imaging and Biopsies: Kidney biopsy for interstitial nephritis, bone marrow aspiration if eosinophilia is profound.
  • Drug History: Detailed history of recent medication use, particularly antibiotics like minocycline.
  • Specific Tests: Ex vivo PBMC culture with minocycline to assess immune response (in research settings).
  • Management

  • First-line Treatment: High-dose corticosteroids (e.g., prednisone) for severe cases involving organ dysfunction. 2
  • Adjunctive Therapy: Discontinue the offending drug immediately upon suspicion.
  • Monitoring: Regular follow-up with CBC, organ function tests, and clinical assessment.
  • Supportive Care: Fluid management, dialysis if renal failure is severe, and symptomatic treatment.
  • Special Populations

  • Pediatrics: Minocycline can cause severe reactions including renal and hepatic failure in adolescents. 2
  • Comorbidities: Patients with darker skin phototypes (V-VI) may experience prolonged and severe DRESS due to potential melanin-minocycline complex formation. 1
  • Key Recommendations

  • Discontinue the offending drug immediately upon suspicion of drug-induced eosinophilia (Evidence: Strong 12).
  • Initiate high-dose corticosteroids for patients with organ involvement or severe systemic symptoms (Evidence: Moderate 2).
  • Monitor patients closely with serial CBCs and organ function tests to guide treatment adjustments (Evidence: Expert opinion 12).
  • References

    1 Maubec E, Wolkenstein P, Loriot MA, Wechsler J, Mulot C, Beaune P et al.. Minocycline-induced DRESS: evidence for accumulation of the culprit drug. Dermatology (Basel, Switzerland) 2008. link 2 Kiessling S, Forrest K, Moscow J, Gewirtz A, Jackson E, Roszman T et al.. Interstitial nephritis, hepatic failure, and systemic eosinophilia after minocycline treatment. American journal of kidney diseases : the official journal of the National Kidney Foundation 2001. link

    Original source

    1. [1]
      Minocycline-induced DRESS: evidence for accumulation of the culprit drug.Maubec E, Wolkenstein P, Loriot MA, Wechsler J, Mulot C, Beaune P et al. Dermatology (Basel, Switzerland) (2008)
    2. [2]
      Interstitial nephritis, hepatic failure, and systemic eosinophilia after minocycline treatment.Kiessling S, Forrest K, Moscow J, Gewirtz A, Jackson E, Roszman T et al. American journal of kidney diseases : the official journal of the National Kidney Foundation (2001)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG